Turn Therapeutics (TTRX) Free Cash Flow (2024 - 2026)

Turn Therapeutics' Free Cash Flow history runs 3 years deep, the most recent figure standing at -$1.6 million for Q1 2026.

• On a quarterly basis, Free Cash Flow fell 436.81% year-over-year to -$1.6 million in Q1 2026; TTM through Mar 2026 was -$3.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$2.6 million, down 90.99% from the prior year.
• Free Cash Flow fell to -$1.6 million in Q1 2026 per TTRX's latest filing, from -$1.2 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$298058.0 in Q1 2025 and bottomed at -$1.6 million in Q1 2026.
• The 3-year median for Free Cash Flow is -$820272.5 (2024), against an average of -$884650.8.
• Across the five-year window, Free Cash Flow slumped 181.04% in 2025 and tumbled 436.81% in 2026, its largest moves.
• Year by year, Free Cash Flow stood at -$430545.0 in 2024, then plunged by 181.04% to -$1.2 million in 2025, then slumped by 32.23% to -$1.6 million in 2026.
• Per Business Quant, the three latest TTRX Free Cash Flow figures stand at -$1.6 million (Q1 2026), -$1.2 million (Q4 2025), and -$298058.0 (Q1 2025).